Professional
Added to YB: 2024-08-02
Pitch date: 2024-06-30
RMD [bullish]
ResMed Inc.
+33.93%
current return
Author Info
No bio for this author
Company Info
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.
Market Cap
$35.9B
Pitch Price
$188.37
Price Target
N/A
Dividend
0.97%
EV/EBITDA
17.86
P/E
25.23
EV/Sales
6.73
Sector
Health Care Equipment and Supplies
Category
value
Auscap Asset Management Portfolio Holding: ResMed Inc.
RMD: CPAP leader, 15% EPS CAGR, 20%+ ROE. GLP-1 concerns overblown; study shows 10.5% higher PAP therapy initiation for GLP-1 users. CPAP remains preferred, immediate benefits vs. GLP-1's 52-week timeline. Strong demand, 1B potential market, 23.5M devices. Trading at discount to historical P/E. Significant growth runway ahead.
Read full article (2 min)